These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31053817)

  • 1. Mayo's impact on patent applications related to biotechnology, diagnostics and personalized medicine.
    Aboy M; Crespo C; Liddell K; Minssen T; Liddicoat J
    Nat Biotechnol; 2019 May; 37(5):513-518. PubMed ID: 31053817
    [No Abstract]   [Full Text] [Related]  

  • 2. US personalized-medicine industry takes hit from Supreme Court.
    Ledford H
    Nature; 2016 Aug; 536(7617):382. PubMed ID: 27558042
    [No Abstract]   [Full Text] [Related]  

  • 3. Supreme Court boosts licensees in biotech patent battles.
    Waltz E
    Nat Biotechnol; 2007 Mar; 25(3):264-5. PubMed ID: 17344866
    [No Abstract]   [Full Text] [Related]  

  • 4. The Supreme Court's revolution in patent eligibility law: alternative protections for biotechnology.
    Taylor DO
    Nat Biotechnol; 2019 Mar; 37(3):227-230. PubMed ID: 30833760
    [No Abstract]   [Full Text] [Related]  

  • 5. US Supreme Court applies strict limits to patents.
    Robertson D
    Nat Biotechnol; 2002 Jul; 20(7):639. PubMed ID: 12089532
    [No Abstract]   [Full Text] [Related]  

  • 6. Patents. U.S. Supreme Court delves into what is and isn't patentable.
    Marshall E
    Science; 2009 Jun; 324(5933):1374. PubMed ID: 19520926
    [No Abstract]   [Full Text] [Related]  

  • 7. Intellectual property. Biotech feels a chill from changing U.S. patent rules.
    Servick K
    Science; 2014 Jul; 345(6192):14-5. PubMed ID: 24994626
    [No Abstract]   [Full Text] [Related]  

  • 8. The Impact of Myriad on the Future Development and Commercialization of DNA-Based Therapies and Diagnostics.
    Wales M; Cartier E
    Cold Spring Harb Perspect Med; 2015 Sep; 5(12):. PubMed ID: 26337114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intellectual property. Supreme Court rules out patents on 'natural' genes.
    Marshall E
    Science; 2013 Jun; 340(6139):1387-8. PubMed ID: 23788772
    [No Abstract]   [Full Text] [Related]  

  • 10. Biotechnology patents under fire.
    Royzman I
    Nat Biotechnol; 2015 Sep; 33(9):925-6. PubMed ID: 26348959
    [No Abstract]   [Full Text] [Related]  

  • 11. Obviousness, hindsight and perspective: the impact of KSR v. Teleflex on biotech and pharmaceutical patents.
    Teitelbaum R; Cohen M
    Nat Biotechnol; 2007 Oct; 25(10):1105-6. PubMed ID: 17921990
    [No Abstract]   [Full Text] [Related]  

  • 12. Genes can't be patented, rules Supreme Court.
    McCarthy M
    BMJ; 2013 Jun; 346():f3907. PubMed ID: 23771229
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibody-patent row could have far-reaching impact on biotech.
    Ledford H
    Nature; 2023 Apr; 616(7955):17. PubMed ID: 36977755
    [No Abstract]   [Full Text] [Related]  

  • 14. Patent protection of diagnostic technology: will recent US Supreme Court decisions change patent strategy?
    Komatani TS
    Pharm Pat Anal; 2015; 4(5):357-62. PubMed ID: 26451906
    [No Abstract]   [Full Text] [Related]  

  • 15. Patents. Signature on visitor's form fuels Stanford v. Roche court battle.
    Marshall E
    Science; 2011 Apr; 332(6026):163. PubMed ID: 21474725
    [No Abstract]   [Full Text] [Related]  

  • 16. Patentability of Stem Cells in the United States.
    Fendrick SE; Zuhn DL
    Cold Spring Harb Perspect Med; 2015 Aug; 5(12):. PubMed ID: 26292987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biotech patents: looking backward while moving forward.
    Eisenberg RS
    Nat Biotechnol; 2006 Mar; 24(3):317-9. PubMed ID: 16525404
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmaceutical patent life-cycle management after KSR v. Teleflex.
    Furrow ME
    Food Drug Law J; 2008; 63(1):275-320. PubMed ID: 18561462
    [No Abstract]   [Full Text] [Related]  

  • 19. Sequenom, the U.S. Supreme Court, and Personalized Medicine.
    Kodroff CA
    Hum Gene Ther Clin Dev; 2016 Jun; 27(2):49-52. PubMed ID: 27267566
    [No Abstract]   [Full Text] [Related]  

  • 20. Who reads patents?
    Ouellette LL
    Nat Biotechnol; 2017 May; 35(5):421-424. PubMed ID: 28486445
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.